1. Home
  2. NUVL vs CUBE Comparison

NUVL vs CUBE Comparison

Compare NUVL & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$123.60

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Logo CubeSmart

CUBE

CubeSmart

HOLD

Current Price

$39.96

Market Cap

8.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
CUBE
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
8.8B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
NUVL
CUBE
Price
$123.60
$39.96
Analyst Decision
Strong Buy
Buy
Analyst Count
16
15
Target Price
$134.75
$44.00
AVG Volume (30 Days)
4.2M
1.9M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
5.34%
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
N/A
$1,123,110,000.00
Revenue This Year
N/A
$0.66
Revenue Next Year
$1,239.49
$2.82
P/E Ratio
N/A
$110.53
Revenue Growth
N/A
5.33
52 Week Low
$71.14
$35.09
52 Week High
$123.69
$43.63

Technical Indicators

Market Signals
Indicator
NUVL
CUBE
Relative Strength Index (RSI) 66.56 46.06
Support Level $98.56 $39.91
Resistance Level $123.62 $40.91
Average True Range (ATR) 0.21 0.77
MACD -0.05 -0.14
Stochastic Oscillator 82.41 24.56

Price Performance

Historical Comparison
NUVL
CUBE

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: